Harbour BioMed announced its wholly owned subsidiary is exercising a warrant agreement to acquire common stock in Spruce ...

Qosina has released its New Product Preview, showcasing more than 500 newly added components designed to help engineers solve ...

AstraZeneca will buy AbelZeta Pharma’s 50% share of development and commercialization rights in China for a CAR-T therapy for ...

suitable for safely storing and administering highly sensitive biologics, including cell and gene therapies, biosimilars, and ...

Syngene International, a global CRDMO, has extended its long-standing strategic collaboration with Bristol Myers Squibb ...

Emmecell, a clinical-stage biotechnology company, has appointed Ramin Valian as Chief Executive Officer (CEO).

The cell and gene therapy sector has never lacked attention, but all too often, the narrative swings from one extreme to ...

Fresenius Kabi and TQ Therapeutics, have entered into a strategic-development agreement under which Fresenius Kabi has an ...

The advent and proliferation of targeted modalities represent an evolutionary leap forward in drug development. By binding ...

Vaximm, which specializes in oral T-cell immunotherapies for cancer, is naming Sébastien Wieckowski, PhD, Chief Scientific ...

Apiject Holdings Inc. has signed a lease for a 30,000-square-foot pharmaceutical manufacturing facility in Apex, North ...

Symeres has announced the appointment of Jurgen Berendsen as Chief Financial Officer (CFO), marking a return to the company ...